الاثنين، 28 يوليو 2008

California Mesothelioma Lawyers, California Mesothelioma Attorneys, Mesothelioma Law Firm

Welcome to the law firm of Paul, Hanley & Harley LLP , and thank you for your interest in our legal services.
Our law practice is a plaintiffs only law firm with expertise in complex personal injury and wrongful death litigation involving mesothelioma, benzene, beryllium, lead, manganese, asbestos, and others.
We are nationally recognized trial lawyers with offices located throughout California, including Berkeley, Westlake Village (Los Angeles), San Francisco, and San Diego.
Our attorneys handle cases in courts throughout California, Nevada, Arizona, and across the United States.
If you or a loved one has been diagnosed with mesothelioma or have been affected by exposure to benzene, beryllium, manganese, asbestos, and other toxic substances, our trial lawyers can help. Finding the right legal representation is likely weighing heavily on your mind. Here you will find helpful information about mesothelioma, lung cancer, and other treatment options that we hope will answer many of your questions during this difficult time. You'll also learn more about our firm, and the exceptional and highly experienced attorneys of Paul, Hanley & Harley LLP, that fight to win for victims of mesothelioma cancer.

Paul, Hanley & Harley LLP, has an outstanding track record of success in cases across the country, and our lawyers are known for their honesty, integrity and compassion. We've built our reputation on mesothelioma-asbestos litigation-representing individuals diagnosed with mesothelioma or serious asbestos-related diseases with dignity and respect. We handle a select number of cases at a time and represent workers and families with the extra special attention required for the best possible outcome in each case. We understand your case is unique, so we take the time to get to know you and your family. Contact us today for a free and confidential consultation. Our Mesothelioma Attorneys discuss your specific case and give you honest answers to your important questions. Our toll free telephone number is 1-800- 933-2244. We look forward to helping you.

About Mesothelioma Lawyers

About Mesothelioma Lawyers


Mesothelioma is a disease that, until recently, was extremely rare.
To date, little is know about the condition. However, as the rate of the disease has increased, a new breed of lawyers – those dealing specifically with mesothelioma lawsuits – have stepped in to fight for the rights of victims afflicted with this disease.
These lawyers and law firms often deal exclusively with mesothelioma victims and their families who wish to claim compensation from the companies that were responsible for their exposure to asbestos.
These mesothelioma lawsuits often result in millions of dollars for the victims when handled by an experienced lawyer or law firm.
Those who have been diagnosed with mesothelioma have every right to file a lawsuit. Many of the companies responsible for exposing workers to asbestos were well aware of its dangers and effects, but still saw fit to let their workers continue with little or no protection against the dust and fibers that emanated from this hazardous material. Now, decades later, the effects of this exposure is taking its toll on American workers just as they reach their golden years. These workers are entitled to compensation and justice for their pain, suffering and loss of life. A mesothelioma lawsuit can provide them with such justice.

Today, there are many mesothelioma lawyers to choose from. The number of lawyers and law firms handling these lawsuits is on the rise. Many of these lawyers have dealt with numerous mesothelioma lawsuits and have a good deal of experience and knowledge about the disease. Those looking for a mesothelioma lawyer should chooser someone that has proven experience in the field. Most reputable lawyers will be happy to provide facts and figures on previous cases that they have handled. However, these lawyers often do not provide private information that might be subject to confidentiality. They can, however, provide you with details on how quickly cases were resolved, how much compensation was successfully obtained and how many mesothelioma lawsuits they have dealt with.

It is also worth finding out about the mesothelioma lawsuits that were not successful, and why they were not successful. It may be something as simple as a missed piece of evidence to failure to comply with sensitive timetables associated with such cases. These elements can make the difference between a successful and an unsuccessful lawsuit. By finding out why some lawsuits resulted in no compensation, you may be able to avoid making the same type of mistake.

It is important that you find a good, experienced mesothelioma lawyer as soon as possible after you have been diagnosed with the disease. Most states have a set time limit in which you can file your lawsuit, and it is very important that you not miss that deadline known as a statute of limitations. Otherwise you may find that you are ineligible to make a claim. You also need to give your lawyer as much time as possible to do the necessary research and put together a solid and case against the negligent parties. In short, the earlier you get to a mesothelioma lawyer, the better your chances of success.

Many people are concerned because they do not know exactly where and when they were exposed to asbestos. Some people may have worked in several different places and been exposed to asbestos on numerous occasions. However, your mesothelioma lawyer can help in identifying products that you were exposed to. If necessary, your mesothelioma lawyer will hire the services of a private investigator to find out where the exposure took place. With some research and digging, the lawyer is generally able to pinpoint the company or companies responsible for the exposure.

Again, this can take time and is another reason why it is so important to find a mesothelioma lawyer as soon as possible after the diagnosis of the cancer has been confirmed. Understandably, patients who have just been told that they have mesothelioma will have a great deal on their minds and filing a lawsuit may not be one of their priorities. However, the timely process of selecting a lawyer and filing your lawsuit can make all the difference in securing the future of your family.

Mesothelioma And The Law

Over recent years, we have seen many multi-million dollar compensation payouts to victims of mesothelioma, the asbestos exposure related cancer. This is a relatively new disease, both in terms of medical and legal awareness, and sufferers of mesothelioma are finding that they are entitled to a hefty compensation in many cases. And to help these victims get their dues,

many lawyers and law firms have been trained and set up to deal with mesothelioma claims in order to get mesothelioma sufferers the compensation to which they are entitled.

Why are mesothelioma victims entitled to compensation? Well, most cancers not the fault of an outsider. Heavy smokers may get cancer through smoking
which is their own choice. Other types of cancer, such as breast, cervical and prostate are not anybody’s fault, although vigilance and regular check ups can help to identify these caners early on and therefore treat them effectively. However, mesothelioma is a totally different type of cancer. This is a cancer that could have been prevented, and it is the fault of outsiders – namely the irresponsible firms that made no efforts to protect their workers against the hazards of working with asbestos. You see, mesothelioma is the result of regular exposure the asbestos dust and fibres, which are ingested into the system and corrupt the cells of the protective lining that surround major organs – the mesothelium. The cancer lies dormant for many decades, and victims do not realise until thirty or forty years later that they have the disease. By the time tests have been done and a diagnosis has been made, it is often too late to do anything constructive about it, and the patient is left with just a short time to live – typically 4-24 months.

These mesothelioma lawyers are here to help victims of mesothelioma to get cold, hard cash from the companies responsible for their doomed fate. This compensation will help to cover medical expenses and pain and suffering. But, perhaps most importantly, it helps to provide financial stability and security for the victim’s loved ones after he or she has passed away.

The payouts for mesothelioma lawsuits have run from hundreds of thousands of dollars, to multi-million dollars. But the mesothelioma sufferer must ensure that the chances of success are optimised by seeking legal advice and assistance as soon as the diagnosis has been confirmed. Most states only provide a certain time within which you can file a mesothelioma lawsuit, so it is vital that you do this immediately. Your lawyer will also need the extra time to put your case together and carry out any necessary research. Time is of the essence where mesothelioma lawsuits are concerned, and just a few days could make the difference between financial security for your family and no compensation at all.

If you are concerned about not having any money up-front to pay for legal costs, don’t be. The vast majority of mesothelioma lawyers work on a contingency fee basis. This means that they do not take any money from you up-front. And if your case is unsuccessful they will not take any money from you at all. You only have to pay the lawyer if and when you receive compensation. Your lawyer will then be entitled to a percentage of the compensation. And, although the cut to which the lawyer is entitled can seem high – generally around the 35% mark – it does mean that you don’t have to worry about paying in order to file for compensation and you have nothing to lose if you don’t get any compensation.

Your mesothelioma lawyer will also be able to give you support and advice with regards to your illness. The experienced mesothelioma lawyers have already built up a network of contacts within the field; not only for legal support but for all types of support and advice. This network means that your lawyer can process your claim more quickly than a lawyer who has little or no knowledge or experience in dealing with mesothelioma lawsuits. The experienced lawyer will also be able to point you in the right direction for additional support services and support groups

Mesothelioma Lawsuits : Frequently Asked Questions

Mesothelioma Lawsuits : Frequently Asked Questions


Who has the right to file for compensation for mesothelioma?


A mesothelioma lawsuit can be filed by a person who has developed mesothelioma through exposure to asbestos. In the event that the person has passed away, the lawsuit can be filed by a family member or the executor of the deceased’s estate. A lawsuit can also be filed by a family member who has developed the disease through close contact with the person who was exposed to asbestos.
How long does the process take?

The process can take quite a while, although there is no set time and some lawyers will get your case sorted faster than others. The more research that is required to put a solid case together, the longer it will take.

How long do I have to file my claim?

This differs from state to state but generally the time limit is one to two years from diagnosis. It is important that you check on the time limitation for your state and act within the limitations otherwise you may not be eligible to claim. If you are claiming on behalf of the deceased, time limitations still apply and it is probably even more important to act quickly because of the time limits and the research required by the lawyer.

What if I don’t know where and when I was exposed to asbestos?

It is helpful if you know this and will certainly speed up the process, but if you don’t remember the lawyer will be able to help. A private investigator can be hired through the lawyer (paid for by the lawyer) who will do the necessary research to clarify when and where the exposure took place and which company or companies are responsible.

How can I afford legal assistance?

You won’t need to worry about having cash up front because mesothelioma lawyers usually work on a no win no fee basis. You will not have to pay a penny unless you receive compensation, and then the lawyer will take a percentage of the compensation as his fee.

How much will I get?

It’s impossible to say how much you will get as it depends on the merits of your case. Your lawyer will discuss this with you in more detail when you go through the details of your claim, but past settlements have notched up hundred of thousands of dollars and even multi-million dollar payouts.

Where can I find a mesothelioma lawyer?

There are now many mesothelioma lawyers and you should have no problem finding one. The Internet is a good place to start your search, as many mesothelioma lawyers advertise there. You can check out many credentials and assess the experience of individual law firms by searching on the Internet. You can also submit your details via the Internet in many cases, allowing the law firm to evaluate your case and then contact you. You can also check in your local phone directory for details of mesothelioma lawyers. However, try to find a lawyer that has experience of working with mesothelioma lawsuits as they will already have a network of resources and contact that could help to process your case more quickly.

Will the lawsuit be filed in the state where I live?
Not necessarily. Your lawyer will select the state in which you have the best chance of success and where you are likely to get the highest compensation. This will make no difference to you as you will not have to pay any extra and may end up getting far more compensation in another state.

Will my case go to court?
Again, it is impossible to say until your lawyer has tried to settle out of court. However, most mesothelioma cases are settled out of court and this saves both sides money because taking the case to court can get costly.

Asbestos Lawyer Asbestos AttorneyMesothelioma is a disease that has been on the rise over recent years.

Mesothelioma is a disease that has been on the rise over recent years.
As cases of the disease have started to increase, lawyers dealing specifically with mesothelioma and asbestos lawsuits have come into operation.
These lawyers and law firms deal,
sometimes exclusively, with mesothelioma victims and their families who wish to claim compensation from the companies that were responsible for their exposure to asbestos.
And mesothelioma lawsuits are often able to collect millions in compensation for the victims
and their families
Those who have been diagnosed with mesothelioma are entitled to file a lawsuit. Many of the companies responsible for exposing their employees to asbestos were well aware of the dangers and effects, but still saw fit to let their workers continue with little or no protection against the dust and fibers that emanated from this hazardous material. Now, decades later, the effects of this exposure is taking its toll on the workers just as they reach or are enjoying retirement. Quite rightly, the workers want to see justice done in the form of compensation, although this will never make up for the pain, suffering and loss of life that many of them have been sentenced to.

Many asbestos lawyers have dealt with numerous mesothelioma and asbestos lawsuits and have a good deal of experience and knowledge about the disease. Those looking for an asbestos lawyer should hunt around for someone that has proven experience in the field. Most reputable lawyers will be only too happy to provide facts and figures on pervious cases. They cannot, of course, name names and intricate details as this would be a breach of confidentiality. However, they can provide you with details on how quickly cases were resolved, how much compensation was successfully obtained and how many mesothelioma lawsuits they have dealt with.

There are many asbestos lawyers in operation today, and most people affected by asbestos will be able to find a local practicing asbestos lawyer. You should do a little research on successful cases as well as unsuccessful cases dealt with by the law firm that you are considering. This will enable you to make a more informed decision with regards to which asbestos lawyer you use for your case, based on the information provided by the lawyer or the law firm. It is important that you find a good, experienced asbestos lawyer as soon as possible after you have been diagnosed with an asbestos related disease such as mesothelioma. Most states have a set time limit in which you can file your lawsuit, and it is very important that you do not miss that deadline otherwise you may find that you are ineligible to make a claim.

When you go and seek assistance from an asbestos lawyer, don’t expect to get all the answers on day one. There is no way of predicting the direction in which your asbestos lawsuit might go, how quickly your case may be settled or how much you may get in compensation. Lawyers must assess each case on its own merits, and the course of action can be determined by any number of factors. However, there are some general guidelines available that could help you learn more about your legal options, and which should be discussed in greater detail with an asbestos lawyer or specialist.

It is useful for the asbestos lawyer if clients can provide as much information as possible with regards to their exposure, but this is not a necessity. Providing you are frank and open with the asbestos lawyer, the law firm can often hire someone to investigate your exposure to asbestos and will do this at no cost to you. And because most asbestos lawyers work on a contingency fee basis, you will pay nothing at all until you receive compensation, and nothing if your case is not successful.


Mesothelioma Lawyers

How to Select a Mesothelioma Attorney ?
Mesothelioma Lawyer – A Real Nightmare to the Asbestos Industry?
Selecting a Mesothelioma Attorney: Consumer Tips Mesothelioma Lawyers
Mesothelioma Lawsuits : Frequently Asked Questions
Mesothelioma And The Law Asbestos Lawyer Asbestos Attorney
About Mesothelioma Lawyers Mesothelioma Law Firm
California Mesothelioma Lawyers, California Mesothelioma Attorneys,
Mesothelioma Law Firm
The mesothelioma lawyers at RPWB have represented hundreds of families harmed by mesothelioma due to asbestos exposure. The lawyers at RPWB have been instrumental in obtaining impressive verdicts and settlements on behalf of mesothelioma victims in many states.
Our mesothelioma lawyers know that each case is different and deserves individual attention and pursue each case with their vast experience and knowledge of mesothelioma and the asbestos industry.

At Richardson, Patrick, Westbrook, & Brickman we believe in justice. We also understand that money will never adequately compensate a victim of mesothelioma, but we feel that asserting victims' rights within the court system sends an important message to the negligent and reckless companies which caused harm to thousands of American workers and their families.

Mesothelioma was preventable if asbestos companies and employers had not chosen personal profit above all else!


السبت، 19 يوليو 2008

Mesothelioma: Questions and Answers

Mesothelioma: Questions and Answers
Mesothelioma: Questions and Answers
Mesothelioma is a rare form of cancer in which malignant (cancerous) cells are found in the mesothelium, a protective sac that covers most of the body’s internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles.
What is the mesothelium?
The mesothelium is a membrane that covers and protects most of the internal organs of the body. It is composed of two layers of cells: One layer immediately surrounds the organ; the other forms a sac around it. The mesothelium produces a lubricating fluid that is released between these layers, allowing moving organs (such as the beating heart and the expanding and contracting lungs) to glide easily against adjacent structures.
The mesothelium has different names, depending on its location in the body. The peritoneum is the mesothelial tissue that covers most of the organs in the abdominal cavity. The pleura is the membrane that surrounds the lungs and lines the wall of the chest cavity. The pericardium covers and protects the heart. The mesothelial tissue surrounding the male internal reproductive organs is called the tunica vaginalis testis. The tunica serosa uteri covers the internal reproductive organs in women.
What is mesothelioma?
Mesothelioma (cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and divide without control or order. They can invade and damage nearby tissues and organs. Cancer cells can also metastasize (spread) from their original site to other parts of the body. Most cases of mesothelioma begin in the pleura or peritoneum.
How common is mesothelioma?
Although reported incidence rates have increased in the past 20 years, mesothelioma is still a relatively rare cancer. About 2,000 new cases of mesothelioma are diagnosed in the United States each year. Mesothelioma occurs more often in men than in women and risk increases with age, but this disease can appear in either men or women at any age.
What are the risk factors for mesothelioma?
Working with asbestos is the major risk factor for mesothelioma. A history of asbestos exposure at work is reported in about 70 percent to 80 percent of all cases. However, mesothelioma has been reported in some individuals without any known exposure to asbestos.
Asbestos is the name of a group of minerals that occur naturally as masses of strong, flexible fibers that can be separated into thin threads and woven. Asbestos has been widely used in many industrial products, including cement, brake linings, roof shingles, flooring products, textiles, and insulation. If tiny asbestos particles float in the air, especially during the manufacturing process, they may be inhaled or swallowed, and can cause serious health problems. In addition to mesothelioma, exposure to asbestos increases the risk of lung cancer, asbestosis (a noncancerous, chronic lung ailment), and other cancers, such as those of the larynx and kidney.
Smoking does not appear to increase the risk of mesothelioma. However, the combination of smoking and asbestos exposure significantly increases a person’s risk of developing cancer of the air passageways in the lung.
Who is at increased risk for developing mesothelioma?
Asbestos has been mined and used commercially since the late 1800s. Its use greatly increased during World War II. Since the early 1940s, millions of American workers have been exposed to asbestos dust. Initially, the risks associated with asbestos exposure were not known. However, an increased risk of developing mesothelioma was later found among shipyard workers, people who work in asbestos mines and mills, producers of asbestos products, workers in the heating and construction industries, and other tradespeople. Today, the U.S. Occupational Safety and Health Administration (OSHA) sets limits for acceptable levels of asbestos exposure in the workplace. People who work with asbestos wear personal protective equipment to lower their risk of exposure.
The risk of asbestos-related disease increases with heavier exposure to asbestos and longer exposure time. However, some individuals with only brief exposures have developed mesothelioma. On the other hand, not all workers who are heavily exposed develop asbestos-related diseases.
There is some evidence that family members and others living with asbestos workers have an increased risk of developing mesothelioma, and possibly other asbestos-related diseases. This risk may be the result of exposure to asbestos dust brought home on the clothing and hair of asbestos workers. To reduce the chance of exposing family members to asbestos fibers, asbestos workers are usually required to shower and change their clothing before leaving the workplace.
What are the symptoms of mesothelioma?
Symptoms of mesothelioma may not appear until 30 to 50 years after exposure to asbestos. Shortness of breath and pain in the chest due to an accumulation of fluid in the pleura are often symptoms of pleural mesothelioma. Symptoms of peritoneal mesothelioma include weight loss and abdominal pain and swelling due to a buildup of fluid in the abdomen. Other symptoms of peritoneal mesothelioma may include bowel obstruction, blood clotting abnormalities, anemia, and fever. If the cancer has spread beyond the mesothelium to other parts of the body, symptoms may include pain, trouble swallowing, or swelling of the neck or face.
These symptoms may be caused by mesothelioma or by other, less serious conditions. It is important to see a doctor about any of these symptoms. Only a doctor can make a diagnosis.
How is mesothelioma diagnosed?
Diagnosing mesothelioma is often difficult, because the symptoms are similar to those of a number of other conditions. Diagnosis begins with a review of the patient’s medical history, including any history of asbestos exposure. A complete physical examination may be performed, including x-rays of the chest or abdomen and lung function tests. A CT (or CAT) scan or an MRI may also be useful. A CT scan is a series of detailed pictures of areas inside the body created by a computer linked to an x-ray machine. In an MRI, a powerful magnet linked to a computer is used to make detailed pictures of areas inside the body. These pictures are viewed on a monitor and can also be printed.
A biopsy is needed to confirm a diagnosis of mesothelioma. In a biopsy, a surgeon or a medical oncologist (a doctor who specializes in diagnosing and treating cancer) removes a sample of tissue for examination under a microscope by a pathologist. A biopsy may be done in different ways, depending on where the abnormal area is located. If the cancer is in the chest, the doctor may perform a thoracoscopy. In this procedure, the doctor makes a small cut through the chest wall and puts a thin, lighted tube called a thoracoscope into the chest between two ribs. Thoracoscopy allows the doctor to look inside the chest and obtain tissue samples. If the cancer is in the abdomen, the doctor may perform a peritoneoscopy. To obtain tissue for examination, the doctor makes a small opening in the abdomen and inserts a special instrument called a peritoneoscope into the abdominal cavity. If these procedures do not yield enough tissue, more extensive diagnostic surgery may be necessary.
If the diagnosis is mesothelioma, the doctor will want to learn the stage (or extent) of the disease. Staging involves more tests in a careful attempt to find out whether the cancer has spread and, if so, to which parts of the body. Knowing the stage of the disease helps the doctor plan treatment.
Mesothelioma is described as localized if the cancer is found only on the membrane surface where it originated. It is classified as advanced if it has spread beyond the original membrane surface to other parts of the body, such as the lymph nodes, lungs, chest wall, or abdominal organs.
How is mesothelioma treated?
Treatment for mesothelioma depends on the location of the cancer, the stage of the disease, and the patient’s age and general health. Standard treatment options include surgery, radiation therapy, and chemotherapy. Sometimes, these treatments are combined.
Surgery is a common treatment for mesothelioma. The doctor may remove part of the lining of the chest or abdomen and some of the tissue around it. For cancer of the pleura (pleural mesothelioma), a lung may be removed in an operation called a pneumonectomy. Sometimes part of the diaphragm, the muscle below the lungs that helps with breathing, is also removed.
Radiation therapy, also called radiotherapy, involves the use of high-energy rays to kill cancer cells and shrink tumors. Radiation therapy affects the cancer cells only in the treated area. The radiation may come from a machine (external radiation) or from putting materials that produce radiation through thin plastic tubes into the area where the cancer cells are found (internal radiation therapy).
Chemotherapy is the use of anticancer drugs to kill cancer cells throughout the body. Most drugs used to treat mesothelioma are given by injection into a vein (intravenous, or IV). Doctors are also studying the effectiveness of putting chemotherapy directly into the chest or abdomen (intracavitary chemotherapy).
To relieve symptoms and control pain, the doctor may use a needle or a thin tube to drain fluid that has built up in the chest or abdomen. The procedure for removing fluid from the chest is called thoracentesis. Removal of fluid from the abdomen is called paracentesis. Drugs may be given through a tube in the chest to prevent more fluid from accumulating. Radiation therapy and surgery may also be helpful in relieving symptoms.
Are new treatments for mesothelioma being studied?
Yes. Because mesothelioma is very hard to control, the National Cancer Institute (NCI) is sponsoring clinical trials (research studies with people) that are designed to find new treatments and better ways to use current treatments. Before any new treatment can be recommended for general use, doctors conduct clinical trials to find out whether the treatment is safe for patients and effective against the disease. Participation in clinical trials is an important treatment option for many patients with mesothelioma.

Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM) Outcomes of an expanded acc

Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM) Outcomes of an expanded access program (EAP)
Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM) Outcomes of an expanded access program (EAP)
SOURCE: ASCO, 2004 Annual Meeting
M. Orlando, A. Wozniak, P. Janne, C. P. Belani, M. L. Keohan, H. Ross, J. Polikoff, D. Mintzer, L. Bloss, C. Obasaju; Lilly Research Laboratories, Indianapolis, IN; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Dana Farber Cancer Institute, Boston, MA; Columbia-Presbyterian Medical Center, New York, NY; Oregon Health Sciences University, Portland, OR; Kaiser Hospital San Diego, San Diego, CA; Pennsylvania Hospital, Philadelphia, PA
Background: The improved efficacy of pemetrexed (ALIMTA, Eli Lilly and Co) in combination with cisplatin versus cisplatin alone, in a phase 3 trial of patients with MPM, has led to a demand for patient access to pemetrexed prior to regulatory approval. An Eli Lilly and Co EAP was opened to allow access to all eligible patients with malignant mesothelioma. This non-randomized study was designed to gather additional efficacy and safety data on pemetrexed alone and in combination with cisplatin. The experience of those previously treated patients with MPM is reported here.
Methods: Previously treated patients with malignant mesothelioma were enrolled in this study. Treatment consisted of pemetrexed 500mg/m2 alone or in combination with cisplatin 75mg/m2. Treatment was administered once every 21 days for a maximum of 6 cycles. All patients received folic acid, vitamin B12, and steroid prophylaxis. Serious adverse events (SAEs) were reported by investigators and compiled in a pharmacovigilence database.
Results: To date, 127 previously treated patients (97M/30F) with pleural mesothelioma have been enrolled. Median age was 65.0 (range = 25.0 to 83.0). An analysis of best tumor response included 31 evaluable patients, which included 4 PRs (12.9%), 6 SDs (19.3%), and 21 PDs (67.7%). The SAE database includes all patients from the EAP with either pleural or peritoneal mesothelioma. SAEs, irrespective of causality, were reported by number of events: nausea (44), vomiting (41), diarrhea (21), renal insufficiency (21), asthenia (13), atrial fibrillation (13), cellulitis (9), constipation (8), dysphagia (4), rash (2), neuropathy (2), stomatitis (2), anemia (12), thrombocytopenia (7), neutropenia (7), and neutropenic fever (4).
Conclusions: Pemetrexed with or without cisplatin in previously treated patients with pleural mesothelioma has a favorable safety profile. The clinical benefit rate of 32.2% indicates activity in this poor prognostic patient population. This trial will conclude in early 2004, and all response and safety data will be forthcoming.

Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma (MPM): Outcomes on Expanded Acces


Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma (MPM): Outcomes on Expanded Access Program (EAP).
SOURCE: ASCO, 2004 Annual Meeting
A. J. Wozniak, P. Janne, C. P. Belani, M. L. Keohan, H. Ross, J. Polikoff, D. Mintzer, C. Obasaju; Wayne State University, Detroit, MI; Dana Farber Cancer Institute, Boston, MA; University of Pittsburgh Cancer Institute, Pittsburgh, PA; Columbia-Presbyterian Medical Center, New York, NY; Oregon Health Sciences University, Portland, OR; Kaiser Hospital San Diego, San Diego, CA; Pennsylvania Hospital, Philadelphia, PA; Lilly Oncology, Indianapolis, IN
Background: The high efficacy rates of pemetrexed in combination with cisplatin in the treatment of MPM demonstrated in a Phase 3 trial has led to a strong demand for patient access to pemetrexed prior to regulatory approval. The Eli Lilly and Company EAP was opened to provide pemetrexed to all prospective patients. This non-randomized, open-label study was designed to gather additional efficacy and safety data of pemetrexed alone or in combination with cisplatin.
Methods: Treatment in chemonaive patients consisted of pemetrexed 500mg/m2 in combination with cisplatin 75mg/m2. It was administered once every 21 days for a maximum of 6 cycles. All patients received folic acid, vitamin B12, and steroid prophylaxis.
Results: To date, 476 patients (400 M/74 F) have been treated in the program. Median age was 70.0 (range = 23.0 to 86.0). Response data available from 295 patients show 10 (3.4%) with CR, 42 (14.2%) with PR, 129 (43.7%) with SD and 114 (38.6%) with PD. SAEs irrespective of causality reported by number of events were; neutropenia (7), neutropenic fever (4), anemia (12) and thrombocytopenia (7), nausea (44), vomiting (41), diarrhea (21), renal impairment (21), atrial fibrillation (13), asthenia (13), cellulites (9), constipation (8), dysphagia (4), rash (4), neuropathy (2) and mucositis (2).
Conclusions: The clinical benefit rate of 61.7% supports that this doublet is effective in the treatment of MPM. The modest number of SAE events reported suggests a favorable toxicity profile.

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in c

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
BACKGROUND: PCR-based evidence of infection by simian virus 40 (SV40) has been reported in varying proportions of pleural mesotheliomas and other tumours, but data are conflicting and reproducibility limited. During a study of SV40 in relation to homozygous deletion of CDKN2A in mesotheliomas, we became concerned by inconsistent results and therefore used several independent techniques to investigate SV40 in these tumours.
METHODS: High-quality DNA and RNA were extracted from 71 frozen mesothelioma samples. DNA PCR was done with four sets of primers for the SV40 T-antigen gene. RNA transcripts were examined by RT-PCR. FINDINGS: The first two primer sets for DNA PCR gave positive results in proportions similar to those reported in positive studies (56-62%) but there were unusual reproducibility difficulties. These primers were in a region of the T-antigen gene (nucleotides 4100-4713) that is present in many common laboratory plasmids. In assays with PCR primers not included within that region, only four cases (6%) showed products but these were too faint to suggest clonal infection. Further PCR assays confirmed that the SV40 sequences in the tumour samples had a deletion found only in plasmids, not in native functional SV40. Review of previous studies showed a similar pattern of discrepancies between SV40 T-antigen DNA PCR results obtained with primers within and beyond the region 4100-4713. All 71 mesotheliomas were negative for T-antigen transcripts by RT-PCR, and lacked T-antigen-positive tumour cells by immunohistochemistry.
INTERPRETATION: Our data based on three independent experimental approaches do not support a significant role for SV40 in human mesotheliomas. The risk of false-positive results due to contamination by common laboratory plasmids containing SV40 sequences has been underestimated. Studies of SV40 based on PCR methods require careful primer design to reduce this risk.
RELEVANCE TO PRACTICE: This paper presents several lines of evidence against the proposed link between SV40 infection and human mesotheliomas. Studies reporting a high prevalence of SV40 DNA in human tumours have been based on molecular assays prone to false-positive results. Because SV40 appears unlikely to have a major role, if any, in human mesotheliomas, clinicians should continue to consider asbestos exposure as the most likely and most thoroughly established aetiological factor in individuals with this cancer.

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma
Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma
Bueno R, Reblando J, Glickman J, Jaklitsch MT, Lukanich JM, Sugarbaker DJ.
Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA
BACKGROUND: Survival after tri-modality therapy with extrapleural pneumonectomy (EPP) and postoperative chemoradiotherapy is longer for patients with epithelial MPM versus mixed or sarcomatoid subtypes, leading some to decline aggressive therapy for patients with nonepithelial histology. However, pathologic diagnosis of malignant pleural mesothelioma (MPM) and subclassification into one of the three histologic subtypes (epithelial, mixed, sarcomatoid) can be challenging. Pleural biopsy has been proposed as the diagnostic gold standard. We investigated the accuracy of open pleural biopsy for diagnosis and subtype identification in MPM.
METHODS: Patients with suspected MPM routinely undergo open pleural biopsy to establish diagnosis. Those diagnosed definitively by pleural biopsy or cytology are offered pleurectomy or EPP dependent on stage and cardiorespiratory status. We reviewed medical records for all patients undergoing EPP at our institution, comparing tissue and subtype diagnosis at initial diagnostic biopsy versus definitive resection.
RESULTS: Between 1988 and 2000, 305 of 332 consecutive patients undergoing EPP had MPM. One patient diagnosed with MPM at pleural biopsy was misclassified. Subtype analysis at pleural biopsy proved correct in 80% (226/282). Most patients (174/192) with epithelial subtype at final diagnosis were diagnosed correctly at pleural biopsy. However, 44% (45/103) with pathologic diagnosis of nonepithelial subtype at resection were initially misdiagnosed with the epithelial subtype. The sensitivity of pleural biopsy for epithelial MPM was 97% with a specificity of 56%.
CONCLUSIONS: Open pleural biopsy is accurate and should be considered the gold standard diagnostic method for MPM. It is less sensitive for determining histologic subclass, particularly with nonepithelial subtypes

Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive

Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy
Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy
SOURCE: Cancer. 2005 Feb 15;103(4):839-49.
Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH.
Program in Peritoneal Surface Malignancy, Department of Surgical Oncology, Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA.
BACKGROUND: Malignant peritoneal mesothelioma is a rare and fatal disease. Until recently, the treatment options were very limited and ineffective. The new comprehensive approach of cytoreductive surgery with perioperative intraperitoneal chemotherapy offers improved survival rates at a cost of considerable morbidity and mortality as in other peritoneal surface malignancies. The outcome after these treatments is predominantly dependent on adequate cytoreduction. The aim of the current study was to identify computed tomography (CT) scan images that are useful in patient selection for this comprehensive approach.
METHODS: An analysis of the preoperative CT scans of 30 patients with peritoneal mesothelioma treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single institution was performed. Based on the size of residual tumor nodules after cytoreductive surgery, patients were divided into 2 groups: those with residual lesions2.5 cm (suboptimal cytoreduction). The CT scans for each patient were evaluated by a standardized scoring system with the reader blinded to the operative findings. Thirty-nine CT scan parameters were obtained and statistically analyzed to determine their association with the study outcome variables, namely, adequacy of cytoreduction.
RESULTS: Seven patients (64%) in the suboptimal cytoreduction group and 2 patients (11%) in the adequate cytoreduction group had a >5-cm tumor mass in the epigastric region (P=0.004). Nine patients (82%) in the suboptimal group and 2 patients (11%) in the adequate cytoreduction group had CT scans that showed loss of normal architecture of the small bowel and its mesentery (P<0.001).>5-cm tumor mass in the epigastric region and loss of normal architecture of the small bowel and its mesentery had an adequate cytoreduction. Patients who lacked these two preoperative CT scan findings had a 94% probability of an adequate cytoreduction.
CONCLUSIONS: CT scans effectively identified large peritoneal mesothelioma tumors at crucial anatomic sites. Because adequate cytoreduction is necessary to achieve prolonged survival, CT scans became an accurate prognostic radiologic test for patient selection for comprehensive treatment. Copyright (c) 2005 American Cancer Society

Extended surgical staging for potentially resectable malignant pleural mesothelioma

Extended surgical staging for potentially resectable malignant pleural mesothelioma
SOURCE: Ann Thorac Surg. 2005 Dec;80(6):1988-92.
Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR.
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
BACKGROUND: Extrapleural pneumonectomy for malignant pleural mesothelioma (MPM) is a high-risk procedure, and patients require careful preoperative staging to exclude advanced disease. Computed tomography, magnetic resonance imaging, and positron emission tomography are useful staging modalities, but do not reliably identify contralateral mediastinal involvement or transdiaphragmatic invasion. We evaluated the role of extended surgical staging procedures, which generally includes a combination of laparoscopy, peritoneal lavage, and mediastinoscopy, to more precisely stage patients with MPM.
METHODS: One hundred eighteen patients with MPM, deemed clinically and radiologically resectable, underwent extended surgical staging. Mediastinoscopy was performed in 111 patients, laparoscopy in 109 patients, and peritoneal lavage in 78 patients.
RESULTS: Ten (9.2%) patients had gross evidence of transdiaphragmatic or peritoneal involvement. Peritoneal lavage was positive for metastatic MPM in 2 (2.6%) patients, neither of whom had obvious transdiaphragmatic invasion. Ipsilateral mediastinal nodes contained metastatic tumor in 10 of 62 (16.1%) patients. Contralateral nodes were positive in 4 of 111 (3.6%) patients. Of the patients who underwent biopsy of both ipsilateral and contralateral mediastinal nodes, and who had complete pathologic staging after extrapleural pneumonectomy (n = 46), 14 (30.4%) had N2-positive nodes. Only 5 of these patients were correctly identified by mediastinoscopy (sensitivity 36%, accuracy 80%). Extended surgical staging identified 16 (13.6%) patients who had contralateral nodal involvement, transdiaphragmatic invasion, or positive peritoneal cytology.
CONCLUSIONS: Extended surgical staging defines an important subset of patients with unresectable MPM not identified by imaging. Because of the potential morbidity associated with extrapleural pneumonectomy, we advocate that extended surgical staging be performed in all patients with MPM before resection.

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma


Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
Allen AM, Czerminska M, Janne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH.
Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.
PURPOSE: To describe the initial experience at Dana-Farber Cancer Institute/Brigham and Women's Hospital with intensity-modulated radiation therapy (IMRT) as adjuvant therapy after extrapleural pneumonectomy (EPP) and adjuvant chemotherapy.
METHODS AND MATERIALS: The medical records of patients treated with IMRT after EPP and adjuvant chemotherapy were retrospectively reviewed. IMRT was given to a dose of 54 Gy to the clinical target volume in 1.8 Gy daily fractions. Treatment was delivered with a dynamic multileaf collimator using a sliding window technique. Eleven of 13 patients received heated intraoperative cisplatin chemotherapy (225 mg/m(2)). Two patients received neoadjuvant intravenous cisplatin/pemetrexed, and 10 patients received adjuvant cisplatin/pemetrexed chemotherapy after EPP but before radiation therapy. All patients received at least 2 cycles of intravenous chemotherapy. The contralateral lung was limited to a V20 (volume of lung receiving 20 Gy or more) of 20% and a mean lung dose (MLD) of 15 Gy. All patients underwent fluorodeoxyglucose positron emission tomography (FDG-PET) for staging, and any FDG-avid areas in the hemithorax were given a simultaneous boost of radiotherapy to 60 Gy. Statistical comparisons were done using two-sided t test.
RESULTS: Thirteen patients were treated with IMRT from December 2004 to September 2005. Six patients developed fatal pneumonitis after treatment. The median time from completion of IMRT to the onset of radiation pneumonitis was 30 days (range 5-57 days). Thirty percent of patients (4 of 13) developed acute Grade 3 nausea and vomiting. One patient developed acute Grade 3 thrombocytopenia. The median V20, MLD, and V5 (volume of lung receiving 5 Gy or more) for the patients who developed pneumonitis was 17.6% (range, 15.3-22.3%), 15.2 Gy (range, 13.3-17 Gy), and 98.6% (range, 81-100%), respectively, as compared with 10.9% (range, 5.5-24.7%) (p = 0.08), 12.9 Gy (range, 8.7-16.9 Gy) (p = 0.07), and 90% (range, 66-98.3%) (p = 0.20), respectively, for the patients who did not develop pneumonitis.
CONCLUSIONS: Intensity-modulated RT treatment for mesothelioma after EPP and adjuvant chemotherapy resulted in a high rate of fatal pneumonitis when standard dose parameters were used. We therefore recommend caution in the utilization of this technique. Our data suggest that with IMRT, metrics such as V5 and MLD should be considered in addition to V20 to determine tolerance levels in future patients.

Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma


Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma
Yan TD, Yoo D, Sugarbaker PH.
Peritoneal Surface Malignancy Program, 106 Irving Street, NW, Suite 3900N, Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA.
BACKGROUND: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and invariably fatal neoplasm. Some studies have shown that cytoreductive surgery (CRS) combined with perioperative intraperitoneal chemotherapy (PIC) achieved an improved survival, as compared to historical controls. However, the significance of lymph node involvement in this disease has never been well defined
METHODS: One hundred patients with DMPM underwent CRS and PIC at the Washington Hospital Center. The inclusion criteria for surgery consisted of histological diagnosis of DMPM, age <80 years and good performance status. All data were collected prospectively. Lymph node status, seven clinical variables and eight treatment-related prognostic factors were analyzed for survival.
RESULTS: Seven patients were lymph node positive and they all died of their disease within 2 years after the surgery. The remaining 93 patients had 5- and 7-year survival of 50% and 43%, respectively. Univariate analysis showed that gender (p<0.001), peritoneal cancer index (p=0.009), lymph node status (p<0.001), extra-abdominal invasion (p=0.026), histological type (p<0.001), intraoperative blood loss (p=0.035), completeness of cytoreduction (p<0.001), intraperitoneal chemotherapy regimen (p=0.041), and redo cytoreductive surgery (p=0.022) were significant for survival. Multivariate analysis demonstrated that female gender, lymph node metastasis not detected, epithelial type, and adequate cytoreduction were independently associated with an improved survival.
CONCLUSIONS: CRS and PIC showed an improved survival for DMPM, as compared to historical controls. Lymph node status along with three other prognostic variables was significant in the multivariate analysis.

mesothelioma study 2


Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging.
Truong MT, Marom EM, Erasmus JJ.
Department of Diagnostic Imaging, Unit 57, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. mtruong@mdanderson.org
PURPOSE: Malignant pleural mesothelioma (MPM) is an uncommon neoplasm arising from mesothelial cells of the pleura. The prognosis is poor with a median survival of 8 to 18 months after diagnosis. Multimodality regimens combining chemotherapy, radiotherapy, immunotherapy, and surgery are being used more frequently in patient management. Extrapleural pneumonectomy is the surgical treatment of choice in 10% to 15% of patients who present with resectable disease and is reported to prolong survival. Accurate staging is important to distinguish patients who are resectable from those requiring palliative therapy. Integrated computed tomography-positron emission tomography (CT-PET) increases the accuracy of overall staging in patients with MPM and significantly improves the selection of patients for curative surgical resection. Specifically, CT-PET detects more extensive disease involvement than that shown by other imaging modalities and is particularly useful in identifying occult distant metastases. This article reviews aspects of imaging performed in the initial staging of patients with MPM according to the International Mesothelioma Interest Group staging system and will emphasize the appropriate role of CT-PET imaging in determining the T, N, and M descriptors.

Mesothelioma Research

Mesothelioma Research
Mesothelioma is a disease that is still very hard to recognise, difficult to diagnose and virtually impossible to treat effectively. It is known that the disease is asbestos related and that there is a long latency period before symptoms become apparent. But with more and more cases coming to light each year, it is vital that further research is carried out in order to make this fatal disease more manageable for both patients and doctors.
Many organizations are involved in research in to mesothelioma. This includes the companies that are responsible for the use of asbestos. Many people that have been diagnosed with mesothelioma have now discovered that they can claim compensation for being exposed to hazardous asbestos by companies, which means that these companies have a responsibility to help with this research.
The National Institute of Cancer is also working hard to research mesothelioma, its symptoms, diagnosis and treatment. The rising number of mesothelioma cases means that it is essential to learn more about this disease in order to look into developing treatments.
With many mesothelioma patients now seeking legal advice, it has become essential for law firms to learn about and research the disease. It is the lawyer’s job to assist the mesothelioma patient and provide advice and resources from which the patient can get help and assistance. Therefore, law firms dealing with these types of cases also have a responsibility to learn about the disease and what can be done to help patients.
A great deal of research into mesothelioma goes into learning about the effects of asbestos upon cells, and how the cells are changed by exposure to this material. By learning how healthy cells and corrupted by asbestos, we hope to learn more about how this cell corruption can be prevented or minimised.
The National Institute of Cancer has also carried out clinical trials into the treatment of mesothelioma. The trials, which are performed with real patients who have been diagnosed with mesothelioma, should help to determine how effective the various treatments are, and hopefully will go some way to helping experts find more effective treatments for the disease.
Mesothelioma trials are based upon treatments that are thought to have some value to patients. But the trials are just that – trials. This means that there are no guarantees and that a great deal more work and research will be required before a conclusive and effective treatment is found. On the upside, many new trials are being carried out on a regular basis, and with the information and technology available to scientists today, the discovery of an effective treatment for mesothelioma patients is just a matter of time.
Medical professionals worldwide are currently involved in clinical trials, and each trial depends upon the extent of spread of the disease. Some trials are performed on those who have been diagnosed reasonably early, others on patients who were not diagnosed until the latter stages of the disease. It is important for scientists to find a treatment that is effective not only on those who are diagnosed early, but on all patients that suffer from this killer disease.
The research carried out into mesothelioma will hopefully mean that future generations of suffers can be saved, even if they are diagnosed with the disease. The research carried out is extremely costly, and is often sponsored by associated companies such as drug companies and research groups as well as by the government. Research into the contraction of the disease, and its subsequent development will ultimately enable professionals to devise the most effective treatment.
Several new methods of treatment have been used following research into mesothelioma. These include:
Photodynamic therapy, which uses fixed frequency light to target abnormal cells and kill them off by the activation of photosensitizing drugs.
Immunotherapy, which fights the abnormal cells through the use of the body’s own defence system through enhancement and development of the immune system.
Intensity Modulated Radiation Therapy, which is a radiation treatment that targets just the affected area/tumour, thus avoiding contact with healthy cells and tissue.
Although there is no quick-fix answer to the treatment of mesothelioma, ongoing research and dedication from the medical profession means that the chances of finding an effective treatment are continually increasing.

Mesothelioma Treatments


Mesothelioma Treatments
With new clinical trials being introduced on a regular basis, there are a variety of treatments being used on mesothelioma. The treatment used is dependant upon a variety of factors, including the extent of the disease, the age and medical history of the patient, and the location and type of the mesothelioma.
The most common treatments are:
Surgery, where the tissue in the affected area is cut out. This may involve removing part of the organ depending on the size of the affected area.
Radiation treatment, which involves the use of radiation treatment to kill off the cancerous cells in the affected area.
Chemotherapy, which is the use of drugs in the body used to kill off the cancerous cells.
Pneumonectomy
A surgical procedure, known as pneumonectomy, can be used for pleural mesothelioma and involves the removal of the diseased lung. An extra-pleural pneumonectomy may be necessary depending upon the spread of the disease, and this may involve the removal of parts of the diaphragm as well as the lung. There is a high risk factor with this surgery, and its viability is dependant upon the patient’s overall health, smoking habits and the extent of the asbestos exposure. A pleurectomy is another type of surgery that may be used, and here part of the chest, abdominal lining and surrounding tissue may be removed.
Radiation treatment
Radiation treatment , which gives the benefit of treating the affected area without exposing the healthy cells and tissue, is another treatment used to treat mesothelioma. This is a speedy and commonly used method for many types of cancer, as well as mesothelioma. It works through the placements of radioactive sources in the affected area, which then give out radiation to kill off the abnormal cells. The radiation continues to transmit for around a year, working to destroy the tumour. Radiation therapy can be used alongside surgery, or if the patient is not well enough for surgery can be used alone.
Chemotherapy treatments
Chemotherapy treatments can be administered in the form of pills or injected medication. The downside of chemotherapy is that the drugs used can contain high toxicity levels and can therefore make patients quite ill. Side effects can include nausea, vomiting, hair loss, weight loss and physical fatigue. There are also a number of post-chemo drugs that are used to alleviate the side effects of the chemotherapy. Because chemotherapy drugs are not targeted towards a specific area, they are left to make their way through the body and find the affected area. This means that they are also able to affect tissue and cells that are unaffected by the disease, which can again cause side effects.
Palliative Therapies
Palliative Therapies may also be used on mesothelioma patients. These therapies entail draining excess fluid from the patient through the use of a needle and suction. To prevent further fluid accumulation drugs may be fed through a tube into the chest following the fluid drainage.
Often, a combination of treatments and a cocktail of drugs have to be used in order to treat mesothelioma patients. Again, the types of treatment used will be dependant upon the age and physical health of the patient as well as upon how far the disease has spread and where it is located.
The above are some of the most common treatments used for the treatment of mesothelioma, but they do not always work effectively on mesothelioma patients. Because of this, sufferers of mesothelioma may be offered treatment as part of a clinical trial as opposed to any of the traditional treatments.
With new mesothelioma cancer treatments are continually being tested through medical research studies, it is hoped that an effective treatment will soon be discovered. These clinical trials enable professionals to asses whether the treatment being tested may one day be effective for general use to treat mesothelioma. And these clinical trials also give hope to the patients who allow themselves to be used as guinea pigs, enabling them to be a part of this important research and find a drug that may help them and others in the same situation

Diagnosing Mesothelioma

The diagnosis of mesothelioma is not always easy. Many doctors are still unfamiliar with the symptoms which could be put down to a number of other, more common diseases. Timely diagnosis of mesothelioma is particularly difficult because of the latency period between contraction and display of symptoms. The symptoms of this cancer may not become evident for decades, which means that by the time it is diagnosed it is in its latter stages and there is little that can be done for the patient.
There are many symptoms that become evident in Pleural mesothelioma patients, many of which are common symptoms in a variety of illnesses and diseases, hence the difficulty in diagnosis. Lower back pain, chest pain and shortness of breath are symptoms of the disease. Some patients also suffer from excessive perspiration, trouble swallowing, weight loss and tiredness. The disease affects the respiratory system, and results from an accumulation of fluid between the lung lining and chest cavity, known as pleural effusion. The other type of mesothelioma, which affects the abdominal lining, is known as peritoneal mesothelioma. The symptoms that may be displayed by patients include nausea, vomiting, weight loss and stomach pains.
The diagnosis of mesothelioma will entail scans and biopsies arranged by your doctor. A CT or MRI scan is often used to detect the possible presence of the disease, and if there is a positive indication of the presence of mesothelioma, the scans are followed up by a biopsy. Doctors often run an examination on the fluid surrounding the lungs, but all too often this is inadequate to make a firm diagnosis. In these circumstances the doctor may perform a small operation in order to remove a tissue sample and run a biopsy on that. This is known as open pleural biopsy. If you are suspected of suffering from peritoneal mesothelioma the biopsy will be performed on tissue taken from the abdominal area, known as a peritoneal biopsy.
Although the open biopsy procedures are considered to be the most effective and conclusive ways of diagnosing mesothelioma according to experts, there are a range of other procedures that doctors may use in order to try and determine whether a patient has the disease.
The testing procedure will start with imaging tests, such as x-rays, CT scans or MRI scans. This will enable the doctor to view the potentially affected area and make a preliminary diagnosis and decide upon the best course of action. The doctor may then use a needle to remove fluid from the affected area and conduct tests to see whether there are any malignant cells present. However, this test is widely thought of as inconclusive and many doctors prefer to follow it up with a tissue biopsy whether or not malignant cells are present.
There are several ways in which the doctor can perform a tissue biopsy in order to test for mesothelioma. A thoracoscopy or laparoscopy entails making a small incision and using a tiny camera to look at the affected area. At this time a small tissue sample can be taken, which is then examined by a pathologist for signs of mesothelioma. Your doctor may decide to do a needle biopsy, where a hollow needle is inserted through the skin and into the chest cavity. The doctor is able to collect a tissue sample with the needle, and this is then examined by the pathologist.
However, most physicians prefer to use an open biopsy as this allows for the collection of a bigger tissue sample making diagnosis easier and more accurate. Once the tissue samples have been collected, a detailed examination of the cells is performed to check for malignant cells in the tissue. Once a diagnosis has been made, further scans may be required to learn the extent of the disease and prescribe treatment.
If you have worked with or had contact with asbestos at any time in your life, it is important that you let your doctor know. The difficulty in diagnosing mesothelioma means that you doctor may put your symptoms down to any number of diseases before testing for mesothelioma. However, if you have already made it known that you have worked with asbestos, it will give the doctor a head start in making a diagnosis. This means that test can be carried out far earlier and the necessary treatment can be prescribed

Symptoms Of Mesothelioma

Symptoms Of Mesothelioma
The long latency period attached to mesothelioma means that the symptoms of this disease can take many years to manifest, making both diagnosis and effective treatment very difficult. And even when the symptoms do become evident, which can take several decades, the symptoms are so generalised and non-specific that they could be put down to any number of more common diseases. This makes it hard for even experienced doctors to make a quick and conclusive diagnosis with mesothelioma patients. The symptoms of this disease can often be confused with pneumonia during its early stages.
Some of the most common symptoms of pleural mesothelioma (which is the most common form of the disease) are shortness of breath and chest pains. This may be accompanied by a persistent cough, and all of these symptoms stem from the build up of fluid between the lining of the lung and the chest cavity. This is known as pleural effusion. This type of the disease starts in the chest cavity and can then spread to other parts of the body. Pleural mesothelioma sufferers may also begin to display severe breathing difficulty, weight loss and fever as well as trouble swallowing and even swelling of the face and neck. Some patients may also develop a rasping voice and start coughing up blood. However, there are other patients that may not show any significant symptoms at all.
The symptoms for patients who suffer from peritoneal mesothelioma (a rarer form of the disease) are slightly different. This type of the disease starts in the abdomen and can spread form there. Patients of peritoneal mesothelioma can display abdominal pain and swelling, nausea, loss of appetite and vomiting. They can also suffer breathing problems, and chest pain in addition to these symptoms. These symptoms result from tumours that lean against the abdominal wall. Bowel obstruction, anaemia, fever and problems with blood clotting may also affect peritoneal mesothelioma patients.
The rarest form of this disease is pericardial mesothelioma, which starts in the cavity surrounding the heart. With pericardial mesothelioma, the tumours grow in the tissues that surround the heart and can spread from there. Pericardial mesothelioma sufferers may experience chest pain, shortness of breath, persistent coughing and palpitations.
As the disease moves into the later stages, the symptoms for all types of mesothelioma become more acute and obvious, although they can still often be put down to another illness. It is therefore important for patients to inform their doctor if they have been exposed to asbestos at any point – or even if they suspect they may have been exposed to asbestos. This will enable the doctor to make a more informed diagnosis rather than basing his diagnosis on guess work. It is also important not to ignore any of these symptoms, especially if they are experienced over a long period. Many people can be exposed to asbestos inadvertently (e.g. through the clothes of someone that has worked with asbestos) so it is important to visit your doctor should any of these symptoms manifest.
With pleural mesothelioma being the most common form of the disease, the symptom associated with this form of the cancer are the most common ones that are displayed by patients. However, it is important to be fully aware of the symptoms for all three types of mesothelioma, particularly for those who have worked in high risk professions where they may have been exposed to asbestos.
Most people who have worked with asbestos in the past do not begin to show symptoms of mesothelioma until thirty to forty years later. By this time, the disease is already spreading and with the delay in diagnosis, makes it impossible to treat in many cases before it is too late. However, the cause, effects and symptoms of mesothelioma are now becoming more widely known by professionals and lay people. This awareness, coupled with the current clinical trials that are being carried out by a variety of organizations gives patients the hope that an effective treatment will one day be available for all stages of the disease.

Asbestos Exposure

Asbestos Exposure
Asbestos is a mineral that can occur naturally in the environment, and is also used by man in a range of products. This material was once widely used in many places, but as the dangers of exposure to asbestos began to come to light, this all changed. However, for many people it was too late, as the damage had already been done. This is because asbestos is responsible for a number of side effects, which can cause anything from discomfort to death. Asbestosis and pleural plaques can result from exposure to asbestos, and more notably so can mesothelioma, a deadly cancer that can take many decades to develop but only a matter of months from the onset of symptoms to kill.
Mesothelioma is caused by ingesting or breathing in loose asbestos fibres, which can then cause scarring and ultimately can lead to this cancer. The cancer can affect the lung, chest, or abdominal cavities, but it also has a very long latency period, which means that it could be thirty years or more before the person even realizes that they have contracted the cancer because this is how long it can take to manifest. The onset of symptoms can take up to fifty years or more in some cases, but once the symptoms have manifested the lifespan of the person can be as short as several months.
Between the 1950s and the 1980s, many people – mainly men – worked in industries where they were exposed to asbestos on a daily basis and for long periods of time. This mineral was so widely used because it was cheap and because of its fire resistant properties. Because the effects of the mineral were largely unknown except for in certain circles at the time, workers did not question the lack of protection or concern displayed with regards to working so closely with asbestos.
However, it is thought that many companies and manufacturers were aware of the deadly effects of this mineral from as early as the 1920s. However, their failure to provide oblivious employees with protection against the effects of asbestos resulted in many people contracting this cancer, and only realizing thirty to fifty years down the line just as they were settling down to enjoy their retirement.
Some of the workers mostly likely to come across asbestos on a day to day basis and therefore most at risk included as insulators, plasterers, electricians, mechanics, bricklayers, carpenters, and other tradesmen. This is because these professionals worked closely with materials and products that contained asbestos. Also at risk were the families of these workers, as they could often ingest or breathe in asbestos fibres from the clothes, skin, or hair of the worker, and this could lead to the same effects.
Millions of workers have been exposed to asbestos over the years, and the unlucky ones have discovered several decades later just what an impact their work had on their health. Many of the cases of mesothelioma coming to light today are in men, as it was mainly men that worked with asbestos several decades ago. These workers are now finding out that they have this cancer and other asbestos related disorders, as the symptoms finally manifest.
The dangers of asbestos exposure have now been far more widely recognised. However, millions of people worldwide have been exposed to this mineral. For these people, living life can be like living on borrowed time, and each year, thousands of new cases of mesothelioma and other asbestos-related cancers are diagnosed.
This figure is likely to increase over the next ten years or so, and many more middle-aged and elderly people could find that they have been harbouring this deadly cancer for the past few decades.
Although it is now known that asbestos exposure is responsible for malignant mesothelioma and other forms of cancer, asbestosis, pleural plaques, and other respiratory and health problems, this mineral can still be found in insulation materials in many places worldwide, and therefore continues to hold its deadly reign over mankind.

Mesothelioma And Asbestos


Mesothelioma And Asbestos
The cause of a number of ailments and diseases, including the deadly cancer mesothelioma, asbestos has actually been in use for centuries. The name asbestos was given to this mineral by the Ancient Greeks, and the word literally means inextinguishable. The Greeks gave it this name because of its amazing fireproof qualities, although they also noted the harmful effects that asbestos had upon workers.
Asbestos is a soft and flexible, which has been widely used for many years for a variety of things. The modern use for this mineral is for insulation, and it has been used in a wide range of items and structures, from ceilings and walls to toasters and hairdryers. This mineral became popular during the industrial revolution as an effective and safe form of insulation – safe in that it was fireproof, but certainly not safe in any other sense. Although the risks involved in using and working with asbestos had been observed several hundred years earlier, these risks were not taken into account when asbestos became widely used for insulation.
It was not until the 1900s that the facts regarding the risks involved to workers began to re-emerge. An English physician carried out a post-mortem on a man who had worked with asbestos for many years, and he found traces of fibres and dust in the man’s lungs. The doctor stated that the man had died due to his exposure to this mineral. Over the next twenty or so years professionals in many countries began to notice the fact that disease, illness and death was uncommonly high amongst asbestos workers.
In the mid 1920s, an English doctor made the first diagnosis of asbestosis, and this was followed by a study which showed that 25% of English asbestos workers showed signs of a related lung disease. Laws were then stepped up in England to provide better ventilation and more protection to workers who were regularly exposed to asbestos. These steps were slowly followed by other countries over the next decade.
This protection was slow to be implemented and did not prove all that effective. Although asbestos manufacturers and companies that used the mineral were now aware of these studies and the risks involved to workers, they continued to use asbestos widely, exposing many workers to the hazards associated with it. These employees continued to work with asbestos, totally oblivious of the harm that it was capable of causing. Asbestos continued to be widely used until the mid-seventies, by which time many workers has been exposed and were already unknowingly affected by what we now know as mesothelioma.
Today, as the disease begins to take its toll on the asbestos workers of the 1950s, 1960s and 1970s, many new cases of the disease are being diagnosed each year. In fact, the number of cases is rising so quickly that many law firms have employed or trained lawyers to deal specifically with these types of cases. The irresponsible companies and manufacturers that were responsible for this exposure have been sued for billions of dollars, with many of them going bankrupt as a result of compensation payouts.
Although the effects of asbestos have been observed, tested and verified, this mineral is still used today in many places around the world. Although the laws and regulations regarding working with asbestos are far more stringent these days, this doesn’t change the fact that this mineral can cause more harm than good and has claimed many victims from all over the world in the form of the deadly disease mesothelioma.